Kynos Therapeutics jobs and careers
About Kynos Therapeutics
Kynos Therapeutics develops KMO inhibitors across key indications in inflammation, immunity, and metabolism.
- Founded
- 2020
- Employees
- 1 to 10
- Total funding
- $9M
Leadership
The top of Kynos Therapeutics's org chart, with how many people report into each leader.
AS
Alison Strutt
Chief Financial Officer
Jobs at Kynos Therapeutics
No open positions right now. Explore more companies on TheJobsMap.